The expression of TRIM33 in KIRC was correlated with various clinical features like individual cancer stages, patient's gender, patient's age, tumor grade, KIRC subtypes, and nodal metastasis status (Figures 1(c)–1(i)). The gene discussed is TRIM33; the disease is neoplasm.